ArticleNPJ precision oncology2026

FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.

Santhosh Kumar Pasupuleti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.